- Home
- MNKD vs PGNY Comparison
MNKD vs PGNY Comparison
Compare MNKD & PGNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNKD
- PGNY
- Stock Information
- Founded
- MNKD 1991
- PGNY 2008
- Country
- MNKD United States
- PGNY United States
- Employees
- MNKD N/A
- PGNY N/A
- Industry
- MNKD Biotechnology: Pharmaceutical Preparations
- PGNY Misc Health and Biotechnology Services
- Sector
- MNKD Health Care
- PGNY Health Care
- Exchange
- MNKD Nasdaq
- PGNY Nasdaq
- Market Cap
- MNKD 1.4B
- PGNY 1.8B
- IPO Year
- MNKD 2004
- PGNY 2019
- Fundamental
- Price
- MNKD $4.56
- PGNY $21.19
- Analyst Decision
- MNKD Buy
- PGNY Buy
- Analyst Count
- MNKD 6
- PGNY 9
- Target Price
- MNKD $8.92
- PGNY $22.71
- AVG Volume (30 Days)
- MNKD 1.5M
- PGNY 1.0M
- Earning Date
- MNKD 05-08-2025
- PGNY 05-08-2025
- Dividend Yield
- MNKD N/A
- PGNY N/A
- EPS Growth
- MNKD 215.86
- PGNY N/A
- EPS
- MNKD 0.10
- PGNY 0.57
- Revenue
- MNKD $297,595,000.00
- PGNY $1,213,181,000.00
- Revenue This Year
- MNKD $14.23
- PGNY $5.72
- Revenue Next Year
- MNKD $14.56
- PGNY $11.43
- P/E Ratio
- MNKD $46.04
- PGNY $37.42
- Revenue Growth
- MNKD 32.50
- PGNY 9.46
- 52 Week Low
- MNKD $4.17
- PGNY $13.39
- 52 Week High
- MNKD $7.63
- PGNY $33.84
- Technical
- Relative Strength Index (RSI)
- MNKD 38.80
- PGNY 37.05
- Support Level
- MNKD $4.42
- PGNY $22.73
- Resistance Level
- MNKD $5.05
- PGNY $23.77
- Average True Range (ATR)
- MNKD 0.18
- PGNY 0.71
- MACD
- MNKD 0.00
- PGNY -0.07
- Stochastic Oscillator
- MNKD 20.59
- PGNY 24.56
About MNKD MannKind Corporation
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.
About PGNY Progyny Inc.
Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.